Plant People, PBC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Plant People, PBC - overview
Established
2017
Location
San Marcos, CA, US
Primary Industry
Food
About
Plant People, Inc. is a US-based company specializing in plant-based supplements aimed at enhancing wellness through natural ingredients, including mushroom and herbal formulations. Founded in 2017, by Gabe Kennedy and CEO and Board Director Hudson Davis‑Ross, Plant People, Inc. focuses on developing products that promote health and wellness through plant-based solutions.
The company has remained consistent in its business strategy, emphasizing a direct-to-consumer sales model. The founders, who have a background in health and wellness, established the company to meet consumer demand for holistic health options. Plant People is headquartered in the US and has engaged in 2 funding deals, with recent venture funding acquired from Unilever Ventures. Plant People specializes in science-backed, plant-based supplements designed to enhance overall wellness.
The company's core offerings include a variety of mushroom and herbal gummies, tinctures, and seasonal snacks, all crafted to support cognitive function, immune health, stress relief, gut health, sleep quality, and beauty. These products are formulated with a focus on being 100% plant-based, gluten-free, and free from the top eight allergens, making them suitable for a broad range of consumers. The primary end users are health-conscious individuals seeking natural supplements to improve their well-being. Plant People's products are marketed primarily in the United States, positioning themselves in the growing health and wellness market.
Plant People generates revenue primarily through direct-to-consumer sales, with a significant emphasis on e-commerce transactions via their website. Customers can purchase individual products or opt for bundles that offer a discount on multiple items. The company markets flagship products such as the WonderSleep Mushroom Gummies and WonderDay Mushroom Gummies, which are designed for specific health benefits such as relaxation and immune support. Pricing structures are established for both single-item purchases and bundled packages, allowing consumers flexibility in their buying choices.
The revenue model is bolstered by promotional offers, including seasonal discounts and community engagement initiatives that encourage repeat purchases among their customer base. In the future, Plant People plans to launch new products designed to enhance its current offerings, focusing on innovations that align with consumer wellness trends. The company aims to expand its market presence beyond the United States, targeting international regions by the end of 2024. The recent venture funding from Unilever Ventures will be utilized to facilitate this expansion and support the development of new product lines.
In November 2025, Plant People, Inc. raised an undisclosed amount of series A funding from Manna Tree Partners and Unilever Ventures.
Current Investors
Unilever Ventures, Manna Tree Partners
Primary Industry
Food
Sub Industries
Snack Foods, Health Foods & Nutritional Supplements, Fitness & Wellness Facilities, Aesthetic Medicine
Website
www.plantpeople.co/
Verticals
E-commerce
Company Stage
Series A
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.